Struggling Axsome Stock Could Bounce Back on Drug Trial Success

Published on November 30, 2022

Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that.

Continue reading on website
Other news

Finnish startup Synergi scoops up new funding to make smart energy consumption simpler for households

November 30, 2022
As energy bills soar and Europe gets swept up with talk of an energy crisis, Finnish startup Synergi has just raised €800k to help households cope. The young startup is aiming to give people simpler tools to make their electricity consumption smarter and more flexible and now plans to launch to a growing market need…. This content is for members only. Visit the site and log in/register to read.The

2 Stocks That Have Wall Street's Stamp of Approval

November 30, 2022
Despite rampant market volatility ahead of the November jobs data, and possible recession fears, experts believe the U.S. economy is resilient enough to handle a potential growth slowdown. Given the...